Does Rallies show Form 4 insider transactions for MIRA?

Yes. Rallies tracks MIRA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is MIRA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MIRA. It does not provide personalized investment advice.

MIRA (MIRA Pharmaceuticals, Inc. Common Stock) Stock Analysis - Insider Trades

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a publicly traded Healthcare sector company. As of May 21, 2026, MIRA trades at $1.00 with a market cap of $41.01M and a P/E ratio of -0.72. MIRA moved +0.00% today. Year to date, MIRA is -35.06%; over the trailing twelve months it is -26.14%. Its 52-week range spans $0.73 to $2.56. Rallies surfaces MIRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MIRA stock inside the company?

Recent MIRA insider activity includes Aminov Erez sold 613.60K, Aminov Erez sold 44.59K, Aminov Erez sold 55.41K, McNulty Brian Patrick sold 200.00K, and Aminov Erez bought 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

MIRA Key Metrics

Key financial metrics for MIRA
Metric	Value
Price	$1.00
Market Cap	$41.01M
P/E Ratio	-0.72
EPS	$-1.35
Dividend Yield	0.00%
52-Week High	$2.56
52-Week Low	$0.73
Volume	415
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-10.44M
Gross Margin	0.00%

Recent MIRA Insider Trades

Aminov Erez sold 613.60K (~$1.29M) on Oct 16, 2025.
Aminov Erez sold 44.59K (~$56.63K) on Nov 20, 2024.
Aminov Erez sold 55.41K (~$77.02K) on Nov 19, 2024.
McNulty Brian Patrick sold 200.00K (~$392.00K) on Aug 28, 2024.
Aminov Erez bought 2.00K (~$2.00K) on May 21, 2024.

Latest MIRA News

MIRA Pharmaceuticals Reports Safe Tolerability and Favorable PK in 57-Volunteer Ketamir-2 Phase 1 Trial — May 14, 2026
MIRA Reports SKNY-1 Preclinical Study Showing 30% Weight Loss, Lipid Normalization — May 13, 2026
MIRA's Mira-55 Shows No CNS Side Effects at Up to 100 mg/kg, Supports IND — Mar 23, 2026
MIRA Completes Ketamir-2 Phase 1 Dosing in 56 Volunteers with No Serious AEs — Mar 4, 2026

MIRA Analyst Consensus

MIRA analyst coverage data. Average price target: $0.00.

Common questions about MIRA

Who is trading MIRA stock inside the company?: Recent MIRA insider activity includes Aminov Erez sold 613.60K, Aminov Erez sold 44.59K, Aminov Erez sold 55.41K, McNulty Brian Patrick sold 200.00K, and Aminov Erez bought 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MIRA?: Yes. Rallies tracks MIRA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MIRA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MIRA. It does not provide personalized investment advice.